Health and Healthcare

Pacira BioSciences : PCRX

All Pacira BioSciences Articles

30 Articles

Lee Jackson | Mar 3, 2017 at 9:55 AM EST

Wedbush Has 3 Biotech Stocks to Buy With Massive Upside Potential

Here are three biotech companies that not only have data that could prove to be huge, but their shares have…

Lee Jackson | Mar 2, 2017 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Activision Blizzard, Anheuser-Busch, Amphenol, Biogen, Goldman Sachs BDC, Pure Storage and More

Thursday’s top analyst upgrades, downgrades and initiations include Activision Blizzard, Anheuser-Busch, Amphenol, Biogen, Goldman Sachs BDC and Pure Storage.

Chris Lange | Mar 1, 2017 at 11:35 AM EST

4 Biopharma Stocks Moving the Market on Wednesday

These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to…

Lee Jackson | Dec 12, 2016 at 8:20 AM EST

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

A series of new Jefferies reports focus on four biotech stocks that have big upside potential, regardless of the political…

Chris Lange | Dec 5, 2016 at 1:05 PM EST

10 Major Pharma and FDA Catalysts Coming in December

24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of December.

Jon C. Ogg | Dec 2, 2016 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Exxon Mobil, International Paper, JC Penney, Lululemon, Ulta Salon and More

The include top analyst upgrades, downgrades and initiations on Friday morning Exxon Mobil, International Paper, J.C. Penney, Lululemon and Ulta…

Lee Jackson | Sep 22, 2016 at 10:35 AM EDT

Analyst Has 3 Biotech Stocks to Buy With Over 100% Upside Potential

The three biotech stocks featured here are rated Outperform at Wedbush and have at least 100% potential upside to the…

Lee Jackson | Aug 3, 2016 at 9:55 AM EDT

4 Biotech Stocks With Up to 300% Upside Potential and Upcoming Catalysts

A new report from Wedbush focuses on upcoming catalysts for biotech stocks in the firm's coverage universe. These four have…

Lee Jackson | Jun 23, 2016 at 10:55 AM EDT

A Biotech and a Medical Device Stock, Each With Massive Upside Potential

Two recent Wedbush research reports focus is on health care companies that not only have data that could prove to…

Chris Lange | Dec 15, 2015 at 1:20 PM EST

Pacira Pharma Soars on Settled FDA Case

Pacira Pharmaceuticals announced that it achieved an amicable resolution with the FDA for a lawsuit filed earlier this year that…

Paul Ausick | Oct 7, 2015 at 4:04 PM EDT

The 52-Week Low Club for Wednesday

ThinkstockOctober 7, 2015: Here are four stocks trading with heavy volume among 28 equities making new 52-week lows today. GoPro…

Lee Jackson | Aug 16, 2014 at 9:15 AM EDT

Top Insider Selling of Stocks This Week from Biotech, Tech, Sam Zell, and More

ThinkstockIn what was yet another very volatile week for the markets, insider selling and insider buying has been active. We…

Jon C. Ogg | Jun 27, 2014 at 8:20 AM EDT

Top Analyst Upgrades and Downgrades: Alcoa, Cigna, Intel, Molina, Teva, UnitedHealth and More

These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Friday, June 27, 2014. They include…

Jon C. Ogg | Mar 18, 2013 at 12:55 PM EDT

7 Active Trading Big Volume Spikes (CHTR, GLUU, INCY, JNPR, PCRX, SLCA, VCLK)

ThinkstockActive traders and more active investors looking for news lists of stocks to buy or other investing ideas often look…

Jon C. Ogg | May 14, 2012 at 7:59 AM EDT

NASDAQ Changes Up Biotech Index Members & Weightings

Index changes are generally speaking a fairly routine event. They can also create underlying moves in the companies added and…

1 2

Pacira BioSciences : PCRX

All Pacira BioSciences Articles

Wedbush Has 3 Biotech Stocks to Buy With Massive Upside Potential

Top Analyst Upgrades and Downgrades: Activision Blizzard, Anheuser-Busch, Amphenol, Biogen, Goldman Sachs BDC, Pure Storage and More

4 Biopharma Stocks Moving the Market on Wednesday

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

10 Major Pharma and FDA Catalysts Coming in December

Top Analyst Upgrades and Downgrades: Exxon Mobil, International Paper, JC Penney, Lululemon, Ulta Salon and More

Analyst Has 3 Biotech Stocks to Buy With Over 100% Upside Potential

4 Biotech Stocks With Up to 300% Upside Potential and Upcoming Catalysts

A Biotech and a Medical Device Stock, Each With Massive Upside Potential

Pacira Pharma Soars on Settled FDA Case

The 52-Week Low Club for Wednesday

Top Insider Selling of Stocks This Week from Biotech, Tech, Sam Zell, and More

Top Analyst Upgrades and Downgrades: Alcoa, Cigna, Intel, Molina, Teva, UnitedHealth and More

7 Active Trading Big Volume Spikes (CHTR, GLUU, INCY, JNPR, PCRX, SLCA, VCLK)

NASDAQ Changes Up Biotech Index Members & Weightings

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Fed’s Rate Freeze Could Sting for Social Security Recipients

Pacira BioSciences : PCRX

All Pacira BioSciences Articles

Wedbush Has 3 Biotech Stocks to Buy With Massive Upside Potential

Top Analyst Upgrades and Downgrades: Activision Blizzard, Anheuser-Busch, Amphenol, Biogen, Goldman Sachs BDC, Pure Storage and More

4 Biopharma Stocks Moving the Market on Wednesday

4 Red-Hot Biotechs Highlight Jefferies Top Stocks to Buy

10 Major Pharma and FDA Catalysts Coming in December

Top Analyst Upgrades and Downgrades: Exxon Mobil, International Paper, JC Penney, Lululemon, Ulta Salon and More

Analyst Has 3 Biotech Stocks to Buy With Over 100% Upside Potential

4 Biotech Stocks With Up to 300% Upside Potential and Upcoming Catalysts

A Biotech and a Medical Device Stock, Each With Massive Upside Potential

Pacira Pharma Soars on Settled FDA Case

The 52-Week Low Club for Wednesday

Top Insider Selling of Stocks This Week from Biotech, Tech, Sam Zell, and More

Top Analyst Upgrades and Downgrades: Alcoa, Cigna, Intel, Molina, Teva, UnitedHealth and More

7 Active Trading Big Volume Spikes (CHTR, GLUU, INCY, JNPR, PCRX, SLCA, VCLK)

NASDAQ Changes Up Biotech Index Members & Weightings

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s